NCT04809168
Neuropathic Spinal Pain in Ankylosing Spondylitis
StatusActive, Not Recruiting
PhaseNot specified
Primary completion
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 8 versions: 7 with changes below, 1 re-verified with no change. See every version on ClinicalTrials.gov ↗
- Notable Eligibility criteria expanded, about 13 words
- Study completion pushed from Dec 2, 2026 to May 2, 2027
- Secondary endpoints: details revised at 2 of 2 entries
- Publications: details revised at 5 of 5 entries
- Minor Study completion date: Dec 2, 2025 to Dec 2, 2026v7
- Minor Study completion date: Nov 2, 2024 to Dec 2, 2025v6
- Notable Primary and study completion dates: Nov 2, 2021 to Nov 2, 2024
- Trial status: Completed to Active, Not Recruiting
- Minor Trial status: Enrolling by Invitation to Completed
- Enrollment target: estimated 300 to confirmed 292
- Primary completion date changed from estimate of Apr 2022 to Nov 2, 2021
- Study completion date changed from estimate of Jun 2022 to Nov 2, 2021
- Notable Eligibility criteria expanded, about 3 words
- Start date changed from estimate of Apr 2021 to Apr 6, 2021
- Secondary endpoints revised (2)
- Study description revised
- Study First Submitted
- Notable: the plan changed
- Minor: routine updates
Endpoints
Primary
Neuropathic pain
Timeframe: Once, at baseline
Sleep quality
Timeframe: Once, at baseline
Secondary (2)
Health related quality of life
Fatigue
Arms and interventions
AS patients
AS patients diagnosed according to the modified New York criteria
Control
Age- and sex-matched control subjects with nociceptive/mechanical pain complaint lasting more than three months
Other: Questionnaires and inventories
Sites
1 site in 1 country
- Izmir Bozyaka Training and Research HospitalIzmir, Turkey (Türkiye)